We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MACOM (MTSI) Reports In-Line Q1 Earnings, Misses on Revenues
Read MoreHide Full Article
MACOM Technology Solutions Holdings, Inc. (MTSI - Free Report) delivered fiscal first-quarter 2019 non-GAAP earnings of 20 cents per share, in line with the Zacks Consensus Estimate. The figure increased 25% on a sequential basis but declined drastically from the year-ago quarter.
The sequential increase in earnings was driven by prudent cost management.
Adjusted revenues increased 15.1% year over year but were flat on a sequential basis at $150.7 million. The figure missed the Zacks Consensus Estimate of $154 million and came in at the lower end of the guided range.
Management said that the results were impacted by trade tensions and recent geopolitical events. Also, orders from cloud customers slowed in the quarter, thereby impacting results.
In addition, the industrial market witnessed sluggishness due to macro slowdown. However, management expects end-market demand to be healthy for 2019, with 5G in particular expected to drive a rebound in the near future.
Operating Details
In fiscal first-quarter 2019, non-GAAP gross margin came in at 56.3%, expanding 260 basis points (bps) on a year-over-year basis and 150 bps sequentially.
Non-GAAP operating expenses, as a percentage of revenues, came in at 41.7%, which contracted 180 bps from the prior-year quarter and 70 bps from fiscal fourth-quarter 2018.
Adjusted operating margin came in at 14.5%, which expanded 420 bps from the prior-year quarter and 220 bps from the fiscal fourth quarter.
Adjusted EBITDA was $29.5 million, up from $20.9million in the year-ago quarter. However, the figure was up from $26.1 million in the fiscal fourth quarter.
Balance Sheet & Cash Flow
At the end of fiscal first quarter, cash equivalents and short-term investments were $185.8 million compared with $192.9 million at the end of the fiscal fourth quarter. Inventories were $120.9 million, down from $122.8 million a year ago.
Long-term debt obligations, excluding current portion, were $659.3 million in the fiscal first quarter.
Guidance
For fiscal second-quarter 2019, MACOM expects adjusted revenues between $134 million and $142 million. The Zacks Consensus Estimate for revenues is pegged at $159.4 million.
The company’s earnings are anticipated in the range of 4-12 cents per share. The Zacks Consensus Estimate for the same is pegged at 24 cents per share.
Further, non-GAAP gross margin is anticipated in the range of 55-57%.
MACOM Technology Solutions Holdings, Inc. Price, Consensus and EPS Surprise
Currently, MACOM carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader technology sector are Twitter , Lumentum Holdings (LITE - Free Report) and Inphi Corporation . While Twitter sports a Zacks #1 Rank (Strong Buy), Lumentum and Inphi both carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for Twitter, Lumentum and Inphi is projected to be 22.1%, 17% and 18.5%, respectively.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Image: Bigstock
MACOM (MTSI) Reports In-Line Q1 Earnings, Misses on Revenues
MACOM Technology Solutions Holdings, Inc. (MTSI - Free Report) delivered fiscal first-quarter 2019 non-GAAP earnings of 20 cents per share, in line with the Zacks Consensus Estimate. The figure increased 25% on a sequential basis but declined drastically from the year-ago quarter.
The sequential increase in earnings was driven by prudent cost management.
Adjusted revenues increased 15.1% year over year but were flat on a sequential basis at $150.7 million. The figure missed the Zacks Consensus Estimate of $154 million and came in at the lower end of the guided range.
Management said that the results were impacted by trade tensions and recent geopolitical events. Also, orders from cloud customers slowed in the quarter, thereby impacting results.
In addition, the industrial market witnessed sluggishness due to macro slowdown. However, management expects end-market demand to be healthy for 2019, with 5G in particular expected to drive a rebound in the near future.
Operating Details
In fiscal first-quarter 2019, non-GAAP gross margin came in at 56.3%, expanding 260 basis points (bps) on a year-over-year basis and 150 bps sequentially.
Non-GAAP operating expenses, as a percentage of revenues, came in at 41.7%, which contracted 180 bps from the prior-year quarter and 70 bps from fiscal fourth-quarter 2018.
Adjusted operating margin came in at 14.5%, which expanded 420 bps from the prior-year quarter and 220 bps from the fiscal fourth quarter.
Adjusted EBITDA was $29.5 million, up from $20.9million in the year-ago quarter. However, the figure was up from $26.1 million in the fiscal fourth quarter.
Balance Sheet & Cash Flow
At the end of fiscal first quarter, cash equivalents and short-term investments were $185.8 million compared with $192.9 million at the end of the fiscal fourth quarter. Inventories were $120.9 million, down from $122.8 million a year ago.
Long-term debt obligations, excluding current portion, were $659.3 million in the fiscal first quarter.
Guidance
For fiscal second-quarter 2019, MACOM expects adjusted revenues between $134 million and $142 million. The Zacks Consensus Estimate for revenues is pegged at $159.4 million.
The company’s earnings are anticipated in the range of 4-12 cents per share. The Zacks Consensus Estimate for the same is pegged at 24 cents per share.
Further, non-GAAP gross margin is anticipated in the range of 55-57%.
MACOM Technology Solutions Holdings, Inc. Price, Consensus and EPS Surprise
MACOM Technology Solutions Holdings, Inc. Price, Consensus and EPS Surprise | MACOM Technology Solutions Holdings, Inc. Quote
Zacks Rank & Key Picks
Currently, MACOM carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader technology sector are Twitter , Lumentum Holdings (LITE - Free Report) and Inphi Corporation . While Twitter sports a Zacks #1 Rank (Strong Buy), Lumentum and Inphi both carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term earnings growth rate for Twitter, Lumentum and Inphi is projected to be 22.1%, 17% and 18.5%, respectively.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>